Papageorgiou, S.G. Kotsianidis, I. Kontos, C.K. Symeonidis, A. Galanopoulos, A. Hatzimichael, E. Poulakidas, E. Diamantopoulos, P. Vassilakopoulos, T.P. Zikos, P. Papadaki, H. Bouronikou, E. Panayiotidis, P. Viniou, N.-A. Pappa, V., Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group, Leukemia Research, (71), 55-59, 2018, Elsevier Ireland Ltd, 0145-2126